Disclosure under SEBI Takeover Regulations

COBRA India (Mauritius) Limited c/o Citco (Mauritius) Limited Level 4, Tower A, 1 Exchange Square, Wall Street, Ebene 72201, Mauritius Tel : +230 404 2600 Fax : +230 404 2601 Date: 15th June, 2026 National Stock Exchange of India Ltd., Kind Attention: Listing Dept Exchange Plaza, Bandra Kurla Complex, Bandra (East), Mumbai – 400051 Email- takeover@nse.co.in, compliance@nse.co.in Dear Sir, SYMBOL: SAKAR Sub.: Disclosure under Regulation 29(1) of Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 In due compliance of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, please find herewith the necessary disclosure as required under Regulation 29(1) of the said Regulations. This disclosure is in due compliance of Regulation 29(3) of SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. Thanking You, Yours truly, For Cobra India (Mauritius) Limited Jean-Marc Lesieur Director Encl: As above CC to: The Board of Directors, Sakar Healthcare Limited Block No. 10/13, Village: Changodar, Sarkhej - Bavla Highway, Tal: Sanand, Ahmedabad – 382 213 Email: info@sakarhealthcare.com, cs@sakarhealthcare.com COBRA India (Mauritius) Limited c/o Citco (Mauritius) Limited Level 4, Tower A, 1 Exchange Square, Wall Street, Ebene 72201, Mauritius Tel : +230 404 2600 Fax : +230 404 2601 Disclosures under Regulation 29(1) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Part- A- Details of the Acquisition Sr. Particulars 1. Name of the Target Company (TC) SAKAR HEALTHCARE LIMITED 2. Name(s) of the acquirer and Persons Acting in Cobra India (Mauritius) Limited Concert (PAC) with the acquirer 3. Whether the acquirer belongs to No Promoter/Promoter group 4. Name(s) of the Stock Exchange(s) where the National Stock Exchange of India Limited shares of TC are Listed 5. Details of the acquisition as follows Number % w.r.t. total % w.r.t. total share/ voting diluted share/ capital wherever voting capital of applicable(*) the TC(**) Before the acquisition / disposal under consideration, holding of acquirer along with PACs of: a) Shares carrying voting rights 1,469,571 6.4532 6.4532 b) Shares in the nature of encumbrance na NIL NIL (pledge/lien/non disposal undertaking/others) c) Voting rights (VR) otherwise than by na NIL NIL shares d) Warrants/ convertible securities (Equity Warrants)/ any other instrument that na NIL NIL entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) e) Total (a+b+c+d) 1,469,571 6.4532 6.4532 Details of acquisition / sale a) Shares carrying voting rights acquired 489,026 2.0462 2.0462 b) VRs acquired otherwise than by equity shares NIL NIL NIL c) Warrants/ convertible securities (Equity Warrants) /any other instrument that entitles the acquirer to receive shares NIL NIL NIL carrying voting rights in the TC (specify holding in each category) acquired d) Shares in the nature of encumbrance NIL NIL NIL (pledge/lien/non disposal undertaking/others) e) Total (a+b+c+d) 489,026 2.0462 2.0462 Page 1 of 3 COBRA India (Mauritius) Limited c/o Citco (Mauritius) Limited Level 4, Tower A, 1 Exchange Square, Wall Street, Ebene 72201, Mauritius Tel : +230 404 2600 Fax : +230 404 2601 Sr. Particulars After the acquisition/sale, holding of acquirer along with PACs of : a) Shares carrying voting rights 980,545 4.4069 4.4069 b) VRs otherwise than by equity shares NIL NIL NIL c) Warrants/ convertible securities (Equity Warrants)/ any other instrument that entitles the acquirer to receive shares NIL NIL NIL carrying voting rights in the TC (specify holding in each category) after acquisition. d) Shares in the nature of encumbrance NIL NIL NIL (pledge/lien/non disposal undertaking/others) e)Total (a+b+c+d) 980,545 4.4069 4.4069 6. Mode of acquisition / sale (e.g. open market /off-market/ public issue/ rights issue/ Open market preferential allotment / inter-se transfer/encumbrance, etc). 7. Salient feature of the securities acquired na including time till redemption, ratio at which it can be converted into Equity Shares, etc. 8. Date of acquisition / sale of shares/ or date of 11.06.2026 receipt of intimation of allotment of shares/VR/Warrants/ convertible securities (Equity warrants)/ any other instrument that entitles the acquirer to receive shares in the TC 9. Equity share capital/ total voting capital of INR 2,22,49,910 the TC before the said acquisition/sale 10. Equity share capital/ total voting capital of the INR 2,22,49,910 TC after the said acquisition 11. Total diluted share/voting capital of the TC INR 2,22,49,910 after the said acquisition For Cobra India (Mauritius) Limited Place: Date: 15th June, 2026 Jean-Marc Lesieur Director Page 2 of 3 COBRA India (Mauritius) Limited c/o Citco (Mauritius) Limited Level 4, Tower A, 1 Exchange Square, Wall Street, Ebene 72201, Mauritius Tel : +230 404 2600 Fax : +230 404 2601 Part – B *** Name of the Target Company: SAKAR HEALTHCARE LIMITED Name(s) of the acquirer and person Whether the acquirer belongs to PAN of the Acquirer and/or PACs acting in concert (PAC) with the Promoter / Promoter Group acquirer Cobra India (Mauritius) Limited No AADCC4379A (Seller) For Cobra India (Mauritius) Limited Place: Date: 15th June, 2026 Jean-Marc Lesieur Director NOTE: (*) Total Share capital/voting capital to be taken as per the latest filing done by the Company to the stock exchange under Listing regulations. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. (***) Part – B shall be disclosed to the Stock Exchanges but shall not be disseminated. Page 3 of 3